Provided by Tiger Trade Technology Pte. Ltd.

TG Therapeutics

55.37
+2.033.81%
Post-market: 55.370.00000.00%17:38 EDT
Volume:1.62M
Turnover:89.13M
Market Cap:8.48B
PE:20.00
High:55.46
Open:53.72
Low:53.36
Close:53.34
52wk High:59.30
52wk Low:26.76
Shares:153.09M
Float Shares:141.54M
Volume Ratio:0.92
T/O Rate:1.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.77
EPS(LYR):2.77
ROE:100.28%
ROA:7.28%
PB:14.03
PE(LYR):19.99

Loading ...

TG Therapeutics Inc - Supplemental Bla Filing for Consolidated Briumvi Dosing Targeted for 2H-2026

THOMSON REUTERS
·
May 27

TG Therapeutics Inc - Single Infusion Safety Consistent With Established Briumvi Profile

THOMSON REUTERS
·
May 27

TG Therapeutics Inc: Phase 3 Trial Met Its Primary Endpoint

THOMSON REUTERS
·
May 27

TG Therapeutics Inc - Secondary Endpoints Consistent With Prior Studies; No New Safety Signals Observed

THOMSON REUTERS
·
May 27

TG Therapeutics Announces Positive Topline Results from Phase 3 ENHANCE Trial

GlobeNewswire
·
May 27

TG Therapeutics Announces Data Presentations for BRIUMVI® at the 2026 Consortium of Multiple Sclerosis Centers Annual Meeting

GlobeNewswire
·
May 26

How Investors May Respond To TG Therapeutics (TGTX) Boosting 2026 Guidance On Stronger Briumvi Sales

Simply Wall St.
·
May 24

TG Therapeutics Raises 2026 Outlook As Briumvi Drives Concentrated Growth

Simply Wall St.
·
May 22

A Look At TG Therapeutics (TGTX) Valuation After Record Q1 Revenue And Higher 2026 Guidance

Simply Wall St.
·
May 10

TG Therapeutics (TGTX) Q1 2026 Results Put 66% Net Margin Narrative To The Test

Simply Wall St.
·
May 08

TG Therapeutics price target raised to $70 from $60 at H.C. Wainwright

TIPRANKS
·
May 07

Analysts’ Opinions Are Mixed on These Healthcare Stocks: TG Therapeutics (TGTX) and Insulet (PODD)

TIPRANKS
·
May 07

Stock Track | TG Therapeutics Soars 15.91% Intraday on Raised Revenue Guidance and Strong Q1 Results

Stock Track
·
May 07

TG Therapeutics Up Over 14%, on Pace for Largest Percent Increase Since August 2024 -- Data Talk

Dow Jones
·
May 07

TG Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 07

TG Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $70 From $60

THOMSON REUTERS
·
May 06

TG Therapeutics Q1 Adj. EPS $0.18 Misses $0.30 Estimate, Sales $204.918M Beat $196.814M Estimate

Benzinga Earnings
·
May 06

TG Therapeutics Q1 revenue rises, lifts 2026 outlook

Reuters
·
May 06

Earnings Flash (TGTX) TG Therapeutics Posts Q1 EPS $0.12, vs. FactSet Est of $0.28

MT Newswires Live
·
May 06

TG Therapeutics Q1 Product Revenue USD 201.308 Million

THOMSON REUTERS
·
May 06